J Neurol Surg B Skull Base 2023; 84(02): 183-191
DOI: 10.1055/a-1762-0167
Original Article

Risk Factors and Functional Outcomes with Early Neurological Deterioration after Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

Hongwei Liu
1   Department of Neurology, Shanxi Medical University, Taiyuan Central Hospital, Shanxi Province, China
,
Yi Zhang
2   Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
,
Haixia Fan
2   Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
,
Chao Wen
1   Department of Neurology, Shanxi Medical University, Taiyuan Central Hospital, Shanxi Province, China
› Author Affiliations

Abstract

Early neurological deterioration (END) is associated with a poor survival after mechanical thrombectomy (MT) in acute ischemic stroke (AIS). To assess risk factors and functional outcomes of END after MT in patients, we analyzed data from 79 patients who received MT with large-vessel occlusion. END after MT in patients is defined as an increase of two points or more in the National Institute of Health Stroke Scale (NIHSS) score, compared with the best neurological status within 7 days. The mechanism of END can be classified into: AIS progression, sICH, and encephaledema. A total of 32 AIS patients (40.5%) had END after MT. Risk factors for END after MT included: history of oral antiplatelet and/or anticoagulation drugs before MT (OR = 9.56,95% CI = 1.02–89.57), higher NIHSS score when admitted to hospital (OR = 1.24, 95% CI = 1.04–1.48), under the subtype of atherosclerotic stroke (OR = 17.36, 95% CI = 1.51–199.56), ASITN/SIR< 2 (OR = 15.78, 95% CI = 1.65–151.26), and prolonged period from AIS onset to the first revascularization (OR = 1.01, 95% CI = 1.00–1.02). AIS patients who had END at early stages were more likely to experience poor outcomes (Modified Rankin Scale [mRS] >2) at 90 days after MT (OR = 6.829, 95% CI = 1.573–29.655). Thus, AIS patients who had experienced END at early stages were more likely to have poor outcomes (mRS >2) at 90 days after MT, and the risk factors of END were connected to the mechanism of END.



Publication History

Received: 31 July 2021

Accepted: 03 February 2022

Accepted Manuscript online:
04 February 2022

Article published online:
03 March 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Takahashi Y, Yamashita T, Morihara R. et al. Different characteristics of anterior and posterior branch atheromatous diseases with or without early neurologic deterioration. J Stroke Cerebrovasc Dis 2017; 26 (06) 1314-1320
  • 2 Jeong HG, Kim BJ, Yang MH, Han MK, Bae HJ. Neuroimaging markers for early neurologic deterioration in single small subcortical infarction. Stroke 2015; 46 (03) 687-691
  • 3 Seners P, Turc G, Oppenheim C, Baron JC. Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry 2015; 86 (01) 87-94
  • 4 Çelik O, Çil C, Biteker FS, Gökçek A, Doğan V. Early neurological deterioration in acute ischemic stroke. J Chin Med Assoc 2019; 82 (03) 245
  • 5 Huang ZX, Wang QZ, Dai YY. et al. Early neurological deterioration in acute ischemic stroke: a propensity score analysis. J Chin Med Assoc 2018; 81 (10) 865-870
  • 6 Siegler JE, Albright KC, George AJ. et al. Time to neurological deterioration in ischemic stroke. Med Student Res J 2017; 4: 18-24
  • 7 Tsivgoulis G, Katsanos AH, Schellinger PD. et al. Successful reperfusion with intravenous thrombolysis preceding mechanical thrombectomy in large-vessel occlusions. Stroke 2018; 49 (01) 232-235
  • 8 Powers WJ, Rabinstein AA, Ackerson T. et al; American Heart Association Stroke Council. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018; 49 (03) e46-e110
  • 9 Han J, Cao YB, Chen KN. et al. The Chinese Academy of Preventive Medicine Stroke Prevention and Control Professional Committee Chinese guidelines for endovascular treatment of acute ischemic stroke. Zhong Guo Zu Zhong Za Zhi 2015; 10: 590-606
  • 10 Hussein HM, Georgiadis AL, Vazquez G. et al. Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study. AJNR Am J Neuroradiol 2010; 31 (03) 454-458
  • 11 Hussein HM, Saleem MA, Qureshi AI. Rates and predictors of futile recanalization in patients undergoing endovascular treatment in a multicenter clinical trial. Neuroradiology 2018; 60 (05) 557-563
  • 12 Xu H, Jia B, Huo X. et al. Predictors of futile recanalization after endovascular treatment in patients with acute ischemic stroke in a Multicenter Registry Study. J Stroke Cerebrovasc Dis 2020; 29 (10) 105067
  • 13 Jia JP, Lv CZ, Cui LY. et al. Chinese guidelines for the diagnosis and treatment of acute ischemic stroke. Zhong Hua Shen Jing Ke Za Zhi 2014; 48: 246-255
  • 14 Kim JM, Moon J, Ahn SW, Shin HW, Jung KH, Park KY. The etiologies of early neurological deterioration after thrombolysis and risk factors of ischemia progression. J Stroke Cerebrovasc Dis 2016; 25 (02) 383-388
  • 15 Higashida RT, Furlan AJ, Roberts H. et al; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003; 34 (08) e109-e137
  • 16 Zhang YH, Shi MC, Wang ZX. et al. The therapeutic effects of endovascular therapy with mTICI2b and 3 recanalization for acute anterior circulation stroke patients. J Stroke Cerebrovasc Dis 2020; 29 (12) 105335
  • 17 Flottmann F, van Horn N, Maros ME. et al; GSR investigators. Early TICI 2b or Late TICI 3-is perfect the enemy of good?. Clin Neuroradiol 2021; 32 (02) 353-360
  • 18 Berkhemer OA, Fransen PS, Beumer D. et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372 (01) 11-20
  • 19 Goyal M, Demchuk AM, Menon BK. et al; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372 (11) 1019-1030
  • 20 Jovin TG, Chamorro A, Cobo E. et al; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372 (24) 2296-2306
  • 21 Saver JL, Goyal M, Bonafe A. et al; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372 (24) 2285-2295
  • 22 Campbell BC, Mitchell PJ, Kleinig TJ. et al; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372 (11) 1009-1018
  • 23 Goyal M, Menon BK, van Zwam WH. et al; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387 (10029): 1723-1731
  • 24 Zi W, Wang H, Yang D. et al; ACTUAL Investigators. Clinical effectiveness and safety outcomes of endovascular treatment for acute anterior circulation ischemic stroke in China. Cerebrovasc Dis 2017; 44 (5-6): 248-258
  • 25 Seners P, Hurford R, Tisserand M. et al. Is unexplained early neurological deterioration after intravenous thrombolysis associated with thrombus extension?. Stroke 2017; 48 (02) 348-352
  • 26 Dzialowski I, Pexman JH, Barber PA, Demchuk AM, Buchan AM, Hill MD. CASES Investigators. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke 2007; 38 (01) 75-79
  • 27 van Kranendonk KR, Treurniet KM, Boers AMM. et al; MR CLEAN investigators. Hemorrhagic transformation is associated with poor functional outcome in patients with acute ischemic stroke due to a large vessel occlusion. J Neurointerv Surg 2019; 11 (05) 464-468
  • 28 Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996; 53 (04) 309-315
  • 29 Nawabi J, Flottmann F, Hanning U. et al. Futile recanalization with poor clinical outcome is associated with increased edema volume after ischemic stroke. Invest Radiol 2019; 54 (05) 282-287
  • 30 Heldner MR, Zubler C, Mattle HP. et al. National Institutes of Health Stroke Scale score and vessel occlusion in 2152 patients with acute ischemic stroke. Stroke 2013; 44 (04) 1153-1157
  • 31 Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke 2012; 43 (11) 2904-2909
  • 32 Strbian D, Meretoja A, Putaala J, Kaste M, Tatlisumak T. Helsinki Stroke Thrombolysis Registry Group. Cerebral edema in acute ischemic stroke patients treated with intravenous thrombolysis. Int J Stroke 2013; 8 (07) 529-534
  • 33 Liebeskind DS, Cotsonis GA, Saver JL. et al; Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Investigators. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol 2011; 69 (06) 963-974
  • 34 Fanou EM, Knight J, Aviv RI. et al. Effect of collaterals on clinical presentation, baseline imaging, complications, and outcome in acute stroke. AJNR Am J Neuroradiol 2015; 36 (12) 2285-2291
  • 35 Albers GW, Marks MP, Kemp S. et al; DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018; 378 (08) 708-718
  • 36 Nogueira RG, Jadhav AP, Haussen DC. et al; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018; 378 (01) 11-21
  • 37 van Kranendonk KR, Treurniet KM, Boers AMM. et al; MR CLEAN Investigators. Clinical and imaging markers associated with hemorrhagic transformation in patients with acute ischemic stroke. Stroke 2019; 50 (08) 2037-2043
  • 38 Bourcier R, Goyal M, Liebeskind DS. et al; HERMES Trialists Collaboration. Association of time from stroke onset to groin puncture with quality of reperfusion after mechanical thrombectomy: a meta-analysis of individual patient data from 7 randomized clinical trials. JAMA Neurol 2019; 76 (04) 405-411
  • 39 Kim BS, Chung PW, Park KY. et al. Burden of intracranial atherosclerosis is associated with long-term vascular outcome in patients with ischemic stroke. Stroke 2017; 48 (10) 2819-2826
  • 40 Tsang ACO, Orru E, Klostranec JM. et al. Thrombectomy outcomes of intracranial atherosclerosis-related occlusions. Stroke 2019; 50 (06) 1460-1466
  • 41 Sugiura Y, Yamagami H, Sakai N, Yoshimura S. Committee of Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Study Group. Predictors of symptomatic intracranial hemorrhage after endovascular therapy in acute ischemic stroke with large vessel occlusion. J Stroke Cerebrovasc Dis 2017; 26 (04) 766-771
  • 42 Fitzgerald S, Rossi R, Mereuta OM. et al. Per-pass analysis of acute ischemic stroke clots: impact of stroke etiology on extracted clot area and histological composition. J Neurointerv Surg 2021; 13 (12) 1111-1116
  • 43 Flottmann F, Brekenfeld C, Broocks G. et al; GSR investigators*. Good clinical outcome decreases with number of retrieval attempts in stroke thrombectomy: beyond the first-pass effect. Stroke 2021; 52 (02) 482-490
  • 44 Mohammaden MH, Haussen DC, Pisani L. et al. Lack of reperfusion rather than number of passes defines futility in stroke thrombectomy: a matched case-control study. Stroke 2021; 52 (09) 2757-2763